| 000 | 01159 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515185447.0 | ||
| 264 | 0 | _c20100622 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a0065-2598 | ||
| 024 | 7 |
_a10.1007/978-0-387-89520-8_14 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFalschlehner, Christina | |
| 245 | 0 | 0 |
_aTRAIL and other TRAIL receptor agonists as novel cancer therapeutics. _h[electronic resource] |
| 260 |
_bAdvances in experimental medicine and biology _c2009 |
||
| 300 |
_a195-206 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xpathology |
| 650 | 0 | 4 |
_aReceptors, TNF-Related Apoptosis-Inducing Ligand _xagonists |
| 650 | 0 | 4 |
_aTNF-Related Apoptosis-Inducing Ligand _xmetabolism |
| 700 | 1 | _aGanten, Tom M | |
| 700 | 1 | _aKoschny, Ronald | |
| 700 | 1 | _aSchaefer, Uta | |
| 700 | 1 | _aWalczak, Henning | |
| 773 | 0 |
_tAdvances in experimental medicine and biology _gvol. 647 _gp. 195-206 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-0-387-89520-8_14 _zAvailable from publisher's website |
| 999 |
_c19157581 _d19157581 |
||